The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 6.00
Ask: 6.40
Change: -0.10 (-1.59%)
Spread: 0.40 (6.667%)
Open: 6.30
High: 6.30
Low: 6.20
Prev. Close: 6.30
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Purchases

12 Dec 2019 07:00

RNS Number : 5921W
Kromek Group PLC
12 December 2019
 

12 December 2019

 

Kromek Group plc

("Kromek" the "Company" or the "Group")

 

Director Share Purchases

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and civil nuclear markets, announces that Sir Peter Williams, Chairman, Dr Arnab Basu, Chief Executive Officer, and Mr Derek Bulmer, Chief Financial Officer, yesterday purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as follows:

 

Name

Title

Number of Ordinary Shares purchased

Price paid per share (pence)

Resulting shareholding

Percentage of issued share capital 

Sir Peter Williams

Chairman

50,000

22.50

200,000

0.06%

Dr Arnab Basu

Chief Executive Officer

20,000

17.95

2,972,000

0.86%

Mr Derek Bulmer

Chief Financial Officer

20,000

17.94

132,292

0.04%

 

 

For further information, please contact:

Kromek Group plc

Arnab Basu, CEODerek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

Max Hartley (NOMAD)Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

Harry ChathliClaire NorburyAlexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

1. Sir Peter Williams

2. Dr Arnab Basu

3. Derek Bulmer

 

2

Reason for the notification

a)

Position/status

1. Chairman

2. Chief Executive Officer

3. Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 22.50p

2. 17.95p

3. 17.94p

1. 50,000

2. 20,000

3. 20,000

 

d)

Aggregated information

- Aggregated volume- Price

 

 N/A

e)

Date of the transaction

11 December 2019

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHTBBBTMBMBTAL
Date   Source Headline
2nd Aug 20227:00 amRNSFinal Results
2nd Aug 20227:00 amRNSKromek wins over $750k in new orders
7th Jul 20227:00 amRNSKromek enters agreement with Smiths Detection Inc.
25th May 20227:00 amRNSNew Nuclear Security order from US federal entity
16th May 202212:07 pmRNSDirector Share Purchase
16th May 20227:00 amRNSBusiness and Trading Update
16th May 20227:00 amRNSAppointment of Nominated Adviser and Broker
4th Apr 20227:00 amRNSNew £1.7m CBRN contract
18th Jan 20227:00 amRNSInterim Results
17th Dec 20214:41 pmRNSSecond Price Monitoring Extn
17th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSNotice of Results
26th Oct 20217:00 amRNSKromek awarded contract by US based OEM customer
29th Sep 20213:14 pmRNSHolding(s) in Company
27th Sep 20211:47 pmRNSDirector Share Purchase
23rd Sep 20217:00 amRNSNuclear security contract from US federal entity
8th Sep 202111:09 amRNSResult of AGM
13th Aug 20213:48 pmRNSNotice of AGM and Publication of Annual Report
3rd Aug 202112:25 pmRNSHolding(s) in Company
15th Jul 202111:05 amRNSSecond Price Monitoring Extn
15th Jul 202111:00 amRNSPrice Monitoring Extension
14th Jul 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSNew Contracts
1st Jul 20217:00 amRNSNotice of Results
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:36 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSKromek awarded new DARPA bio-threat contract
12th May 20212:50 pmRNSDirector Share Purchase
11th May 20217:00 amRNSBusiness and Trading Update
21st Apr 20214:32 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSKromek awarded Nuclear Detection contract
4th Mar 20211:32 pmRNSHolding(s) in Company
2nd Mar 20218:30 amRNSPDMR Dealings
1st Mar 20212:53 pmRNSResults of Placing, Open Offer and General Meeting
1st Mar 20217:00 amRNSNew Medical Screening and Nuclear Security orders
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:01 pmRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSPosting of Circular
12th Feb 202111:05 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 202110:30 amRNSPlacing and Open Offer to raise up to £13 million
4th Feb 20212:00 pmRNSIssue of Equity and Total Voting Rights
26th Jan 20215:15 pmRNSHolding(s) in Company
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20219:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.